本页面由Tiger Trade Technology Pte. Ltd.提供服务

Spruce Biosciences, Inc.

44.05
-1.4900-3.27%
盘后:44.050.00000.00%19:30 EDT
成交量:8.38万
成交额:367.25万
市值:1.27亿
市盈率:-1.15
高:45.04
开:44.84
低:42.80
收:45.54
52周最高:199.20
52周最低:40.33
股本:287.40万
流通股本:228.65万
量比:1.18
换手率:3.66%
股息:- -
股息率:- -
每股收益(TTM):-38.4300
每股收益(LYR):-50.8298
净资产收益率:-105.98%
总资产收益率:-40.03%
市净率:1.51
市盈率(LYR):-0.87

数据加载中...

2024/01/30

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/08

重要事件披露

Form 8-K - Current report
2023/11/13

重要事件披露

Form 8-K - Current report
2023/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/14

重要事件披露

Form 8-K - Current report
2023/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/30

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/26

重要事件披露

Form 8-K - Current report
2023/05/25

重要事件披露

Form 8-K - Current report
2023/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/15

重要事件披露

Form 8-K - Current report
2023/04/05

SEC问询函

CORRESP [Cover] - Correspondence
2023/03/16

重要事件披露

8-K - Current report
2023/03/16

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/16

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/27

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/23

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals